Cystein, Intestinal Thiols and Goblet Cell Development

半胱氨酸、肠硫醇和杯状细胞发育

基本信息

  • 批准号:
    7087054
  • 负责人:
  • 金额:
    $ 25.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposal originates from our observations of a three to four fold increase in the number of acidomucin-positive goblet cells accompanied by glutathione (GSH) depletion in the small intestinal mucosa of neonatal pigs being nourished parenterally. We hypothesize that the lack of luminal cysteine is the primary insult perceived by the parenterally nourished epithelium, and that the functional endpoint of this nutritional deficiency is a more oxidized intracellular redox potential The identification of this amino acid as a key nutritional factor is based on (a) the high rate of first-pass consumption of dietary cysteine and the low rate of arterial cysteine utilization by the intestine; (b) evidence that cellular redox status is a key determinant of cellular differentiation, and (c) the fact that cysteine is structurally and functionally involved in both intracellular redox status and mucosal defense via its inherent contribution to the thiol buffers GSH and thioredoxin (Trx) on one hand, and the goblet cell-specific secretory mucins and intestinal trefoil factor (ITF) on the other. We hypothesize that parenteral nutrition results in a preferential activation of the mucous cell lineage as well as selective sparing of goblet cells leading to the repopulation (at a reduced rate) of the villus with goblet cells relative to absorptive enterocytes. The alteration in goblet cell development is initiated by hyperoxia that stems from compromised cysteine status. In other words, we hypothesize that goblet cells are the guardians of mucosal redox homeostasis. Our hypothesis will be tested in three specific aims: 1) Determine if a causal relationship exists between epithelial redox status and goblet cell expansion, independent of TPN-associated inflammation. 2) Quantify, in a goblet cell culture model system, the hierarchy of cysteine usage for the synthesis of GSH and Trx versus ITF and secretory mucins, as well as the role of the transsulfuration pathway in the formation of cysteine and sulfate from methionine, as affected by apical versus basal provision of cysteine, and in response to graded levels of hyperoxia. Simultaneously, determine if the source (inorganic vs. cysteine-derived) and flux of sulfate used for sulfomucin biosynthesis is affected by cysteine availability and hyperoxic stress. 3) Test the hypothesis that Cysl31 and/or Cys165, found within the activation domain of Cdx2, are redox sensitive and upon post-translational modification alter the specificity of Cdx2 transcriptional regulation.
描述(由申请方提供):该提议源于我们观察到肠外营养新生猪小肠粘膜中酸性粘蛋白阳性杯状细胞数量增加3 - 4倍,伴有谷胱甘肽(GSH)耗竭。我们假设缺乏鲁米那半胱氨酸是肠外营养上皮细胞感受到的主要损伤,并且这种营养缺乏的功能终点是更氧化的细胞内氧化还原电位。将这种氨基酸鉴定为关键营养因子是基于(a)膳食半胱氨酸的高首过消耗率和肠动脉半胱氨酸利用率低;(B)细胞氧化还原状态是细胞分化的关键决定因素的证据,和(c)半胱氨酸在结构和功能上参与细胞内氧化还原状态和粘膜防御的事实,一方面通过其对巯基缓冲剂GSH和硫氧还蛋白(Trx)的固有贡献,另一方面通过其对杯状细胞特异性分泌粘蛋白和肠三叶因子(ITF)的固有贡献。我们假设肠外营养会导致粘液细胞谱系的优先激活以及杯状细胞的选择性保留,从而导致相对于吸收性肠细胞,绒毛中杯状细胞的重新繁殖(速度降低)。杯状细胞发育的改变是由半胱氨酸状态受损引起的高氧引起的。换句话说,我们假设杯状细胞是粘膜氧化还原稳态的监护人。我们的假设将在三个特定的目标进行测试:1)确定上皮氧化还原状态和杯状细胞扩张之间是否存在因果关系,独立于TPN相关炎症。 2)在杯状细胞培养模型系统中,定量GSH和Trx与ITF和分泌性粘蛋白合成的半胱氨酸使用等级,以及转硫途径在蛋氨酸形成半胱氨酸和硫酸盐中的作用,受顶部与基底半胱氨酸供应的影响,并响应分级的高氧水平。同时,确定用于磺粘蛋白生物合成的硫酸盐的来源(无机与半胱氨酸衍生)和通量是否受半胱氨酸可用性和高氧应激的影响。 3)测试Cdx 2激活结构域中发现的Cysl 31和/或Cysl 65是氧化还原敏感的并且在翻译后修饰时改变Cdx 2转录调控的特异性的假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rex Gaskins其他文献

Rex Gaskins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rex Gaskins', 18)}}的其他基金

Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk
细菌硫的饮食调节
  • 批准号:
    9751249
  • 财政年份:
    2016
  • 资助金额:
    $ 25.19万
  • 项目类别:
Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk
细菌硫的饮食调节
  • 批准号:
    9094223
  • 财政年份:
    2016
  • 资助金额:
    $ 25.19万
  • 项目类别:
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation
基于 FRET 的生物传感器可监测细胞周期调节中的氧化还原
  • 批准号:
    8305728
  • 财政年份:
    2010
  • 资助金额:
    $ 25.19万
  • 项目类别:
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation
基于 FRET 的生物传感器可监测细胞周期调节中的氧化还原
  • 批准号:
    7946135
  • 财政年份:
    2010
  • 资助金额:
    $ 25.19万
  • 项目类别:
FRET-based Biosensors to Monitor Redox in Cell Cycle Regulation
基于 FRET 的生物传感器可监测细胞周期调节中的氧化还原
  • 批准号:
    8129427
  • 财政年份:
    2010
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cystein, Intestinal Thiols and Goblet Cell Development
半胱氨酸、肠硫醇和杯状细胞发育
  • 批准号:
    6911639
  • 财政年份:
    2003
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cystein, Intestinal Thiols and Goblet Cell Development
半胱氨酸、肠硫醇和杯状细胞发育
  • 批准号:
    6678652
  • 财政年份:
    2003
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cystein, Intestinal Thiols and Goblet Cell Development
半胱氨酸、肠硫醇和杯状细胞发育
  • 批准号:
    7261250
  • 财政年份:
    2003
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cystein, Intestinal Thiols and Goblet Cell Development
半胱氨酸、肠硫醇和杯状细胞发育
  • 批准号:
    6762359
  • 财政年份:
    2003
  • 资助金额:
    $ 25.19万
  • 项目类别:
ENVIRONMENTAL MODULATION OF INTESTINAL SULFIDOGENS AND I
肠道硫化物和 I 的环境调节
  • 批准号:
    6178806
  • 财政年份:
    1999
  • 资助金额:
    $ 25.19万
  • 项目类别:

相似国自然基金

基于cysteine代谢在内皮损伤中的作用探讨其在SARSCoV-2感染的致病机理及可能的治疗机制
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    万元
  • 项目类别:
    国际(地区)合作与交流项目

相似海外基金

The Bioorganic Chemistry of Electrophilic Sulfur in Cysteine Post-Translational Modifications
半胱氨酸翻译后修饰中亲电硫的生物有机化学
  • 批准号:
    2313438
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
    Standard Grant
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Regulation of CSE-Derived Hydrogen Sulfide in the Heart
CSE 衍生的硫化氢在心脏中的调节
  • 批准号:
    10659832
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
  • 批准号:
    10715408
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Defining Nuclear H2O2 Regulation by Covalent Regulators
通过共价调节剂定义核 H2O2 调节
  • 批准号:
    10725269
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
  • 批准号:
    10732666
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Structural dynamics of voltage-gated ion channels and their implications for ion permeation and drug modulation
电压门控离子通道的结构动力学及其对离子渗透和药物调节的影响
  • 批准号:
    10583283
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
  • 批准号:
    10589578
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach
半导体生物材料加速骨骼愈合:生物工程驱动的方法
  • 批准号:
    10587508
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
  • 批准号:
    10584428
  • 财政年份:
    2023
  • 资助金额:
    $ 25.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了